Page 36 - GTM-3-3
P. 36

Global Translational Medicine                                  Computational advances in cancer liquid biopsy



               sequencing of single-cell genomes and transcriptomes. Nat   70.  Ponomaryova AA, Rykova EY, Gervas PA, Cherdyntseva NV,
               Methods. 2015;12(6):519-522.                       Mamedov IZ, Azhikina TL. Aberrant methylation of LINE-1
                                                                  transposable elements: A  search for cancer biomarkers.
               doi: 10.1038/nmeth.3370
                                                                  Cells. 2020;9(9):2017.
            60.  Cheng YH, Chen YC, Lin E,  et al. Hydro-Seq enables
               contamination-free high-throughput single-cell RNA-     doi: 10.3390/cells9092017
               sequencing for circulating tumor cells.  Nat Commun.   71.  Su SF, De Castro Abreu AL, Chihara Y, et al. A panel of three
               2019;10(1):2163.                                   markers  hyper-  and hypomethylated  in urine sediments
                                                                  accurately predicts bladder cancer recurrence. Clin Cancer
               doi: 10.1038/s41467-019-10122-2
                                                                  Res. 2014;20(7):1978-1989.
            61.  Pixberg C, Schulz W, Stoecklein N, Neves R. Characterization      doi: 10.1158/1078-0432.CCR-13-2637
               of DNA methylation in circulating tumor cells.  Genes.
               2015;6(4):1053-1075.                            72.  Ross JP, Rand KN, Molloy PL. Hypomethylation of repeated
                                                                  DNA sequences in cancer. Epigenomics. 2010;2(2):245-269.
               doi: 10.3390/genes6041053
                                                                  doi: 10.2217/epi.10.2
            62.  Gkountela S, Castro-Giner F, Szczerba BM, et al. Circulating
               tumor cell clustering shapes DNA methylation to enable   73.  Burns KH. Transposable elements in cancer. Nat Rev Cancer.
               metastasis seeding. Cell. 2019;176(1-2):98-112.e14.  2017;17(7):415-424.
               doi: 10.1016/j.cell.2018.11.046                    doi: 10.1038/nrc.2017.35
            63.  Chimonidou M, Strati A, Tzitzira A, et al. DNA methylation   74.  Annapragada AV, Niknafs N, White JR, et al. Genome-wide
               of tumor suppressor and metastasis suppressor genes in   repeat landscapes in cancer and cell-free DNA. Sci Transl
               circulating tumor cells. Clin Chem. 2011;57(8):1169-1177.  Med. 2024;16(738):eadj9283.
               doi: 10.1373/clinchem.2011.165902                  doi: 10.1126/scitranslmed.adj9283
            64.  Peneder P, Stütz AM, Surdez D, et al. Multimodal analysis   75.  Park MK, Lee JC, Lee JW, Hwang SJ. Alu cell-free DNA
               of cell-free DNA whole-genome sequencing for pediatric   concentration, Alu index, and LINE-1 hypomethylation as
               cancers  with  low mutational  burden.  Nat  Commun.   a cancer predictor. Clin Biochem. 2021;94:67-73.
               2021;12(1):3230.                                   doi: 10.1016/j.clinbiochem.2021.04.021
               doi: 10.1038/s41467-021-23445-w                 76.  Douville C, Lahouel K, Kuo A, et al. Machine learning to detect
            65.  Cristiano S, Leal A, Phallen J,  et al. Genome-wide cell-  the SINEs of cancer. Sci Transl Med. 2024;16(731):eadi3883.
               free DNA fragmentation in patients with cancer.  Nature.      doi: 10.1126/scitranslmed.adi3883
               2019;570(7761):385-389.
                                                               77.  Reggiardo RE, Maroli SV, Peddu V,  et al. Profiling of
               doi: 10.1038/s41586-019-1272-6                     repetitive RNA sequences in the blood plasma of patients
            66.  Ulz P, Perakis S, Zhou Q, et al. Inference of transcription   with cancer. Nat Biomed Eng. 2023;7(12):1627-1635.
               factor binding from cell-free DNA enables tumor      doi: 10.1038/s41551-023-01081-7
               subtype prediction and early detection.  Nat Commun.
               2019;10(1):4666.                                78.  Aceto N, Bardia A, Wittner BS, et al. AR expression in breast
                                                                  cancer CTCs associates with bone metastases. Mol Cancer
               doi: 10.1038/s41467-019-12714-4                    Res. 2018;16(4):720-727.
            67.  Wong D, Luo P, Oldfield LE, et al. Early cancer detection in      doi: 10.1158/1541-7786.MCR-17-0480
               Li-Fraumeni syndrome with cell-free DNA. Cancer Discov.
               2024;14(1):104-119.                             79.  Chen C, Mahalingam D, Osmulski P, et al. Single‐cell analysis
                                                                  of circulating tumor cells identifies cumulative expression
               doi: 10.1158/2159-8290.CD-23-0456                  patterns of EMT‐related genes in metastatic prostate cancer.
            68.  Grabuschnig S, Soh J, Heidinger P, et al. Circulating cell-  Prostate. 2013;73(8):813-826.
               free DNA is predominantly composed of retrotransposable      doi: 10.1002/pros.22625
               elements and non-telomeric satellite DNA.  J  Biotechnol.   80.  D’Avola D, Villacorta-Martin C, Martins-Filho SN,  et al.
               2020;313:48-56.
                                                                  High-density single cell mRNA sequencing to characterize
               doi: 10.1016/j.jbiotec.2020.03.002                 circulating tumor cells in hepatocellular carcinoma.  Sci
                                                                  Rep. 2018;8(1):11570.
            69.  Papasotiriou I, Pantopikou K, Apostolou P. L1
               retrotransposon expression in circulating tumor cells. PLoS      doi: 10.1038/s41598-018-30047-y
               One. 2017;12(2):e0171466.
                                                               81.  Papadaki MA, Stoupis G, Theodoropoulos PA, Mavroudis  D,
               doi: 10.1371/journal.pone.0171466                  Georgoulias  V,  Agelaki  S.  Circulating  tumor  cells  with


            Volume 3 Issue 3 (2024)                         13                              doi: 10.36922/gtm.3063
   31   32   33   34   35   36   37   38   39   40   41